This company continues to spin off and acquire other businesses, strengthening its medical and commercial strategy.
Danaher Corporation (DHR)
From Shortex Market Letter
Danaher Corporation (DHR)
TODAY’S PRICE: $140.41
52wk H. 144.50 52wk L. 94.59
Mkt Cap: $99.17B, EPS: 3.41, P/E: 40.48
Beta: 0.84, Div/Yld: 0.68(0.50%)
Danaher Corporation is a global conglomerate marketer of medical, and commercial consumer products. Reported Q2-19 earnings of $731.33M or $1.19/shr up 3.5% yr/yr on revenue increase of 3.5%, $5.2B.
The company purchase of GE’s Biopharma and spinoff of its dental segment is a plus.
The stock is in ascending move since late April ’19. Reversal rocketed (123-126) to (127-130) to (132-144). In correction/retraction stage challenging 50-DMA (140-142 and upper-resistance (142-144).
The shares are volatile.
BUYING RANGE: 133-141
NR TERM OBJ: 151
INTERMED OBJ: 173
STOP LOSS: 125
Joseph Parnes, Shortex Market Letter, www.shortex.com, 800-877-6555, August 29, 2019